{"id":"NCT02251275","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease","officialTitle":"A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long Term Safety of Immediate-release Tolvaptan (OPC-41061, 30 mg to 120 mg/Day, Split Dose) in Subjects With Autosomal Dominant Polycystic Kidney Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-17","primaryCompletion":"2018-11-09","completion":"2018-11-09","firstPosted":"2014-09-29","resultsPosted":"2019-11-27","lastUpdate":"2019-11-27"},"enrollment":1803,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Polycystic Kidney, Autosomal Dominant"],"interventions":[{"type":"DRUG","name":"Tolvaptan","otherNames":["OPC-41061"]}],"arms":[{"label":"Tolvaptan","type":"EXPERIMENTAL"}],"summary":"The purpose of the trial was to evaluate and describe the long term safety of tolvaptan in participants with autosomal dominant polycystic kidney disease (ADPKD).","primaryOutcome":{"measure":"Number Of Participants Reporting Treatment-Emergent Adverse Events (TEAEs)","timeFrame":"Baseline through end of treatment (up to 42 months) and follow-up 7 days posttreatment(+ 7 days)","effectByArm":[{"arm":"Tolvaptan (From 156-13-210: Tolvaptan)","deltaMin":473,"sd":null},{"arm":"Tolvaptan (From 156-13-210: Placebo)","deltaMin":531,"sd":null},{"arm":"Tolvaptan (From 156-08-271: Tolvaptan)","deltaMin":640,"sd":null},{"arm":"Tolvaptan (From Other: Tolvaptan)","deltaMin":6,"sd":null},{"arm":"Tolvaptan (From Other: Placebo)","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":210,"countries":["United States","Argentina","Australia","Belgium","Canada","Czechia","Denmark","Germany","Hungary","Israel","Italy","Netherlands","Norway","Poland","Romania","Russia","South Africa","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["37250503","36191725","33376102"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":87,"n":505},"commonTop":["Thirst","Renal Pain","Polyuria","Hypertension","Nasopharyngitis"]}}